Home Löffler Endocarditis and Endomyocardial Fibrosis
Article Open Access

Löffler Endocarditis and Endomyocardial Fibrosis

  • Matthew J. Flanigan , Michael R. Velez , Emily A. Ruden and Scott M. Lilly
Published/Copyright: September 1, 2017

A 65-year-old man presented to a medical center with dyspnea, peripheral edema, and orthopnea. Diagnosis of chronic systolic and diastolic biventricular heart failure secondary to Löffler endocarditis and endomyocardial fibrosis was made. A transthoracic echocardiograph showed a reduced left ventricular ejection fraction and severe right ventricular systolic dysfunction. The right ventricular cavity was nearly obliterated by a homogeneous mass, and spectral Doppler ultrasonography demonstrated diminished antegrade systolic flow across the pulmonic valve. Anticoagulation therapy with heparin was initiated. Cardiac magnetic resonance image revealed diffuse hyperenhancement of the right ventricular free wall on delayed gadolinium enhancement (image A, arrow). Catheterization of the right side of the heart with contrast ventriculogram revealed a nearly obliterated (image B, dotted line) right ventricle with interatrial passage of contrast and subsequent left ventricular opacification (image B, arrows). A 35-cm ultrasound-accelerated thrombolysis catheter was placed in the left pulmonary artery. Hemodynamic measurements demonstrated atrialization of the right ventricular pressure waveform. Hemodynamics failed to improve after 18 hours of thrombolysis, and the patient died of complications of biventricular heart failure 10 days after presentation.

Löffler endocarditis and endomyocardial fibrosis, when encountered together, is rare and characterized by peripheral eosinophilia and the development of endomyocarditis, intracardiac thrombosis, and eventual cardiac fibrosis.1 Patients with peripheral eosinophilia have been successfully treated with systemic steroids or eradication of the underlying parasitic infection.2,3 Thrombectomy to manage intracardiac thrombosis secondary to Löffler endocarditis has been reported with variable results.4,5


From the Department of Internal Medicine (Drs Flanigan, Velez, Ruden, and Lilly) and the Division of Cardiovascular Medicine (Drs Velez, Ruden, and Lilly) at Ohio State University in Columbus.
Financial Disclosures: None reported.
Support: None reported.

*Address correspondence to Matthew J. Flanigan, MD, 395 W 12th Ave, Columbus, OH 43210-1252. E-mail:


References

1. Olsen EG , SpryC. Relation between eosinophilia and endomyocardial disease. Prog Cardiovasc Dis . 1985;27(4):241-254.10.1016/0033-0620(85)90008-8Search in Google Scholar

2. Rezaizadeh H , Sanchez-RossM, KaluskiE, KlapholzM, HaiderB, GerulaC. Acute eosinophilic myocarditis: diagnosis and treatment. Acute Card Care . 2010;12(1):31-36. doi:10.3109/17482940903578998Search in Google Scholar PubMed

3. Kawano S , KatoJ, KawanoN, et al.Clinical features and outcomes of eosinophilic myocarditis patients treated with prednisolone at a single institution over a 27-year period.Intern Med. 2011;50:975-978.10.2169/internalmedicine.50.4079Search in Google Scholar PubMed

4. Tanaka H , KawaiH, TatsumiK, et al. Surgical treatment for Löffler's endocarditis with left ventricular thrombus and severe mitral regurgitation: a case report. J Cardiol. 2006;47(4):207-213.Search in Google Scholar

5. Jategaonkar S , ButzT, FaberL. Surgical treatment of the hypereosinophilic syndrome with cardiac involvement (Löffler's endocarditis) [in German]. Dtsch Med Wochenschr. 2008;133(12):570-572. doi:10.1055/s-2008-1067283Search in Google Scholar PubMed

Received: 2016-11-21
Accepted: 2016-12-21
Published Online: 2017-09-01
Published in Print: 2017-09-01

© 2017 American Osteopathic Association

This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.

Downloaded on 10.9.2025 from https://www.degruyterbrill.com/document/doi/10.7556/jaoa.2017.115/html
Scroll to top button